What part do relapses play in severe disability for people with MS?

November 4, 2009

ST. PAUL, Minn. -People with multiple sclerosis (MS) who have relapses within the first five years of onset appear to have more severe disability in the short term compared to people who do not have an early relapse, according to a new study published in the November 4, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the first to examine how MS relapses affect people during different time periods of the disease.

Research shows that 85 percent of people with MS begin by having the relapsing-remitting form of the disease and the majority of these people later develop secondary progressive MS. A relapse is defined in the study as worsening of neurological symptoms for more than 24 hours, without a fever or infection. Because relapse-related symptoms often improve within a few weeks, it's been unclear how much disability comes from relapses, and how much from progression.

For the study, scientists reviewed the of 2,477 people with MS who experienced relapses in British Columbia, Canada. The study looked at whether the participants had disability severe enough to require the use of a cane for walking and whether this was related to relapses occurring within five years, five to 10 years, or more than 10 years after onset of symptoms. The participants were followed for an average of 20 years. During that time, the group experienced 11,722 relapses.

Scientists found that people who had a relapse within five years of disease onset were at a 48 percent higher hazard (a measure of relative risk) of needing a cane to walk within five years of disease onset than those who did not have an early relapse. Importantly, the impact of the early relapse lessened over time. Those with early relapse who did not need a cane after five years were at only a 10 percent higher hazard (a measure of relative risk) of needing one 10 years after disease onset than those without early relapses.

"Our findings may represent an important message to people diagnosed with MS today. Those who have a history of relapses could potentially be offered reassurance that as time goes on, these relapses will have a diminishing effect on their everyday lives," said study author Helen Tremlett, PhD, with the University of British Columbia in Vancouver. "In addition, our study calls upon the need for new medications that target axonal degeneration, which is suspected of causing permanent disability, especially for people who have had MS for many years or who are older at diagnosis."

The impact of relapses that occurred later, either at five to 10 or more than 10 years after the start of the disease, also waned over time and became insignificant after long-term follow up. Relapses in people under 25 had a longer impact on disability compared to those over 35 years.

"There may be a longer window of opportunity for treating younger people with MS right away, changing the course of progression later on," Tremlett said.

Source: American Academy of Neurology (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (1 vote)


November 4, 2009 all stories

Comments: 0

5 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • Relapses more frequent in patients diagnosed with pediatric-onset multiple sclerosis
    created Jan 12, 2009 | popularity not rated yet | comments 0
  • Can breastfeeding reduce multiple sclerosis relapses?
    created Feb 19, 2009 | popularity not rated yet | comments 0
  • Obesity, other health problems delay MS diagnosis
    created Oct 29, 2008 | popularity not rated yet | comments 0
  • Adding steroid drug to MS treatment may reduce disease activity
    created Apr 30, 2009 | popularity not rated yet | comments 0
  • If MRI shows signs of MS, will the disease develop?
    created Dec 10, 2008 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

  • Obsessive Compulsive Disorder
    created Nov 20, 2009
  • West's zone 2 starling resistor respiratory physiology
    created Nov 18, 2009
  • 50-0-50 rule
    created Nov 18, 2009
  • What is the evidence in support of the anti-vaccine movement?
    created Nov 17, 2009
  • More from Physics Forums - Medical Sciences

Other News

Surface bacteria maintain skin's healthy balance

Medicine & Health / Research

created 4 minutes ago | popularity not rated yet | comments 0

On the skin's surface, bacteria are abundant, diverse and constant, but inflammation is undesirable. Research at the University of California, San Diego School of Medicine now shows that the normal bacteria living on the ...


New understanding about mechanism for cell death after stroke leads to possible therapy

Medicine & Health / Research

created 3 minutes ago | popularity not rated yet | comments 0

Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which ...


Swine flu vaccine effective despite mutations: experts

Medicine & Health / Diseases

created 20 hours ago | popularity 1 / 5 (1) | comments 1

Swine flu vaccines are still effective despite reported cases of mutations in the A(H1N1) virus, health experts in Europe and North America said Saturday.


Study raises concerns about outdoor second-hand smoke

Medicine & Health / Health

created Nov 18, 2009 | popularity 1.8 / 5 (5) | comments 21

Indoor smoking bans have forced smokers at bars and restaurants onto outdoor patios, but a new University of Georgia study in collaboration with the Centers for Disease Control and Prevention suggests that these outdoor smoking ...


smoking, cigarette

Vaccine being developed to help smokers quit

Medicine & Health / Medications

created Nov 20, 2009 | popularity 4.5 / 5 (12) | comments 10

(PhysOrg.com) -- Glaxo-SmithKline has joined forces with Nabi Pharmaceuticals to produce a vaccine to help smokers give up their addiction permanently.